BIOLARGO, INC. (BLGO) has a 5-year average return on invested capital (ROIC) of -88.4%. This is below average and may indicate limited pricing power.
BIOLARGO, INC. (BLGO) has a market capitalization of $34M. It is classified as a small-cap stock.
BIOLARGO, INC. (BLGO) does not currently pay a regular dividend.
BIOLARGO, INC. (BLGO) operates in the Chemicals & Allied Products industry, within the Materials sector.
BIOLARGO, INC. (BLGO) generated $-8 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
BIOLARGO, INC. (BLGO) has a debt-to-equity ratio of 0.81. This indicates moderate leverage.
BIOLARGO, INC. (BLGO) reported earnings per share (EPS) of $-0.04 in its most recent fiscal year.
ITEM 1. BUSINESS USE OF FORWARD-LOOKING STATEMENTS IN THIS REPORT This annual report on Form 10-K for the year ended December 31, 2025 (the “Annual Report”) contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical fact, included in this Annual Report regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management are forward-looking statements. These forward-looking statements include, but are not limited to, predictions regarding: our business plan; the commercial viability of our technology and products incorporating our technology; the effects of competitive factors on our technology and products incorporating our technology; expenses we will incur in operating our business; our liquidity and sufficiency of existing cash; the success of our financing plans; and the outcome of pending or threatened litigation.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | 12M | - | - |
| Net Income | -12M | -12M | -2.4M | -3.5M | -4.5M | -7.1M |
| EPS | $-0.04 | $-0.04 | $-0.01 | $-0.01 | $-0.02 | $-0.03 |
| Free Cash Flow | -8.3M | -8.3M | -4.4M | -2.8M | -3.0M | -4.0M |
| ROIC | -343.6% | -343.6% | -43.0% | -75.9% | -100.6% | -134.2% |
| Gross Margin | - | - | - | 50.3% | - | - |
| Debt/Equity | 0.81 | 0.81 | 0.30 | 0.21 | 0.25 | 0.27 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -15M | -15M | -4.3M | -4.6M | -5.4M | -6.8M |
| Operating Margin | 0.0% | - | - | -37.4% | - | - |
| ROE | -291.4% | -182.7% | -30.6% | -59.8% | -93.9% | -152.2% |
| Shares Outstanding | 295M | 295M | 240M | 350M | 224M | 236M |
| Metric | 2018 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 12M | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 50.3% | N/A | N/A | N/A |
| R&D | 643K | 685K | 1.4M | 1.6M | 1.7M | 1.5M | 1.3M | 1.4M | 1.3M | 2.3M | 2.9M | 2.6M | 2.6M |
| SG&A | 2.8M | 3.6M | 3.7M | 4.4M | 5.3M | 6.1M | 7.5M | 6.2M | 6.7M | 8.1M | 9.3M | 12M | 12M |
| EBIT | -3.4M | -4.2M | -4.9M | -5.9M | -6.4M | -6.7M | -7.6M | -6.8M | -5.4M | -4.6M | -4.3M | -15M | -15M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -37.4% | N/A | N/A | 0.0% |
| Net Income | -3.7M | -5.1M | -7.8M | -9.1M | -10M | -11M | -8.4M | -7.1M | -4.5M | -3.5M | -2.4M | -12M | -12M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -28.7% | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 342K | 197K | 394K | 0 | 14K | 14K |
| Returns on Capital | |||||||||||||
| ROIC | N/M | -180.1% | -151.4% | N/M | N/M | N/M | -131.5% | -134.2% | -100.6% | -75.9% | -43.0% | N/M | N/M |
| ROE | N/A | -1437.2% | N/A | 335.9% | N/A | N/A | -218.6% | -152.2% | -93.9% | -59.8% | -30.6% | -182.7% | -291.4% |
| ROA | -1725.8% | -465.8% | -389.7% | -505.3% | -320.9% | -295.2% | -170.6% | -234.2% | -113.5% | -53.6% | -25.7% | -125.2% | -141.7% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -1.7M | -1.9M | -3.7M | -4.3M | -3.9M | -4.4M | -4.2M | -3.9M | -2.8M | -2.4M | -3.2M | -8.3M | -8.3M |
| Free Cash Flow | -1.7M | -1.9M | -3.8M | -4.3M | -3.9M | -4.5M | -4.2M | -4.0M | -3.0M | -2.8M | -4.4M | -8.3M | -8.3M |
| Owner Earnings | -5.1M | -3.7M | -4.5M | -5.4M | -5.3M | -6.0M | -6.7M | -5.8M | -4.9M | -4.6M | -5.7M | -11M | -11M |
| CapEx | 0 | 0 | 62K | 29K | 58K | 35K | 23K | 21K | 271K | 478K | 1.2M | 46K | 46K |
| Maint. CapEx | 11K | 11K | 14K | 30K | 50K | 65K | 58K | 20K | 45K | 103K | 462K | 145K | 145K |
| Growth CapEx | N/A | N/A | 48K | 0 | 8K | 0 | 0 | 0 | 226K | 375K | 773K | 0 | 0 |
| D&A | 11K | 11K | 14K | 30K | 50K | 65K | 58K | 20K | 45K | 103K | 462K | 145K | 145K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 3.4M | 1.8M | 751K | 1.1M | 1.3M | 1.5M | 2.5M | 1.9M | 2.1M | 2.1M | 2.1M | 3.0M | 3.0M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 175K | 36K | 37K | 26K | 27K | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 296K | 1.5M | 3.9M | 5.8M | 2.6M | 3.9M | 696K | -664K | -644K | -2.1M | -890K | -627K | -627K |
| Cash & Equiv. | 154K | 1.8M | 1.9M | 990K | 655K | 655K | 716K | 962K | 1.9M | 3.5M | 3.5M | 3.9M | 3.9M |
| Long-Term Debt | 200K | 3.2M | 5.3M | 1.5M | 1.3M | 700K | 507K | 180K | 237K | 289K | 1.1M | 2.1M | 2.1M |
| Debt/Equity | -1.15 | 9.23 | -4.38 | -1.65 | -2.60 | -2.40 | 0.55 | 0.27 | 0.25 | 0.21 | 0.30 | 0.81 | 0.81 |
| Interest Coverage | -9.7 | -4.2 | -1.6 | -1.5 | -1.8 | -1.7 | -3.9 | -29.0 | -101.7 | -50.3 | -61.0 | -27.5 | -27.5 |
| Equity | -392K | 352K | -1.3M | -4.1M | -1.5M | -2.2M | 3.9M | 4.7M | 4.9M | 6.8M | 8.9M | 4.0M | 4.0M |
| Total Assets | 261K | 1.9M | 2.1M | 1.5M | 3.2M | 3.6M | 4.9M | 3.0M | 4.9M | 8.2M | 11M | 8.3M | 8.3M |
| Total Liabilities | 592K | 769K | 2.9M | 4.9M | 4.3M | 5.8M | 5.2M | 2.1M | 2.8M | 4.0M | 4.5M | 6.8M | 6.8M |
| Intangibles | N/A | N/A | N/A | N/A | 1.9M | 1.9M | 2.1M | 0 | 3.0M | N/A | N/A | N/A | N/A |
| Retained Earnings | -79M | -84M | -92M | -101M | -112M | -123M | -132M | -139M | -144M | -147M | -150M | -161M | -161M |
| Working Capital | -422K | 1.4M | 862K | -3.1M | -1.5M | -3.3M | -2.0M | 427K | 1.6M | 3.7M | 4.5M | 51K | 51K |
| Current Assets | 231K | 1.9M | 2.0M | 1.2M | 955K | 1.1M | 1.5M | 1.8M | 3.2M | 6.4M | 7.1M | 5.1M | 5.1M |
| Current Liabilities | 653K | 460K | 1.2M | 4.2M | 2.5M | 4.4M | 3.5M | 1.4M | 1.6M | 2.7M | 2.6M | 5.1M | 5.1M |
| Per Share Data | |||||||||||||
| EPS | -0.05 | -0.06 | -0.09 | -0.10 | -0.09 | -0.08 | -0.05 | -0.03 | -0.02 | -0.01 | -0.01 | -0.04 | -0.04 |
| Owner EPS | -0.07 | -0.04 | -0.05 | -0.06 | -0.05 | -0.04 | -0.04 | -0.02 | -0.02 | -0.01 | -0.02 | -0.04 | -0.04 |
| Book Value | -0.01 | 0.00 | -0.02 | -0.05 | -0.01 | -0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.01 | 0.01 |
| Cash Flow/Share | -0.02 | -0.02 | -0.04 | -0.05 | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.03 | -0.04 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 73.8M | 84.3M | 87.1M | 91.2M | 113.6M | 133.6M | 168.6M | 236.0M | 223.7M | 350.4M | 240.2M | 294.5M | 294.5M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -2.9 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 119.8 | N/A | N/A | N/A | N/A | 5.2 | 60.7 | 25.0 | 7.5 | 6.8 | N/A | 8.4 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 11.0 | 4.6 | 4.4 | N/A | N/A |
| FCF Yield | -6.6% | -4.5% | -5.1% | -12.1% | -14.5% | -13.9% | -20.6% | -7.0% | -6.0% | -5.6% | -7.4% | N/A | -24.6% |
| Market Cap | 26M | 42M | 74M | 36M | 27M | 32M | 20M | 57M | 50M | 51M | 60M | 0 | 34M |
| Avg. Price | 0.52 | 0.42 | 0.53 | 0.51 | 0.29 | 0.24 | 0.17 | 0.19 | 0.22 | 0.19 | 0.26 | 0.00 | 0.12 |
| Year-End Price | 0.35 | 0.50 | 0.85 | 0.39 | 0.24 | 0.24 | 0.12 | 0.20 | 0.17 | 0.17 | 0.20 | 0.00 | 0.12 |
BIOLARGO, INC. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 50.3%.
BIOLARGO, INC. (BLGO) has a return on equity (ROE) of -182.7%. A negative ROE may indicate losses or negative equity.
BIOLARGO, INC. (BLGO) has a 5-year average gross margin of 50.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for BIOLARGO, INC. (BLGO), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
BIOLARGO, INC. (BLGO) has a book value per share of $0.01, based on its most recent annual SEC filing.
No recent press releases.